Literature DB >> 2715897

Dyslipoproteinemia in juvenile rheumatoid arthritis.

N T Ilowite1, P Samuel, L Beseler, M S Jacobson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2715897     DOI： 10.1016/s0022-3476(89)80148-9

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  10 in total

1.  Juvenile idiopathic arthritis activity and function ability: deleterious effects in periodontal disease?

Authors:  Camila Pugliese; Roberta T A van der Vinne; Lucia M A Campos; Priscila R Guardieiro; Cynthia Saviolli; Eloisa Bonfá; Rosa M R Pereira; Vilma S Viana; Eduardo F Borba; Clovis A Silva
Journal:  Clin Rheumatol       Date:  2015-12-01       Impact factor: 2.980

2.  Drug therapy of hypercholesterolaemia in children and adolescents.

Authors:  Marjet J A M Braamskamp; Frits A Wijburg; Albert Wiegman
Journal:  Drugs       Date:  2012-04-16       Impact factor: 9.546

3.  Plasma lipids and lipoproteins in juvenile chronic arthritis.

Authors:  A Bakkaloglu; B Kirel; S Ozen; U Saatçi; N Beşbaş
Journal:  Clin Rheumatol       Date:  1996-07       Impact factor: 2.980

4.  HDL function and subclinical atherosclerosis in juvenile idiopathic arthritis.

Authors:  Preethi Mani; Kiyoko Uno; MyNgan Duong; Kathy Wolski; Steven Spalding; M Elaine Husni; Stephen J Nicholls
Journal:  Cardiovasc Diagn Ther       Date:  2016-02

5.  Decreased high-density lipoprotein cholesterol levels in polyarticular juvenile idiopathic arthritis.

Authors:  Roberta Gonçalves Marangoni; Andre L Hayata; Eduardo F Borba; Pedro M Azevedo; Eloisa Bonfá; Claudia Goldenstein Schainberg
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

6.  Assessment of the body composition and parameters of the cardiovascular risk in juvenile idiopathic arthritis.

Authors:  Ewa Jednacz; Lidia Rutkowska-Sak
Journal:  Biomed Res Int       Date:  2015-03-09       Impact factor: 3.411

7.  Lipid profiles alter from pro-atherogenic into less atherogenic and proinflammatory in juvenile idiopathic arthritis patients responding to anti TNF-α treatment.

Authors:  Kuo-Wei Yeh; Chi-Ming Lee; Chee-Jen Chang; Yu-Jr Lin; Jing-Long Huang
Journal:  PLoS One       Date:  2014-03-06       Impact factor: 3.240

8.  Lipoprotein cholesterol fractions are related to markers of inflammation in children and adolescents with juvenile idiopathic arthritis: a cross sectional study.

Authors:  Anna-Helene Bohr; Freddy Karup Pedersen; Claus Henrik Nielsen; Klaus Gottlob Müller
Journal:  Pediatr Rheumatol Online J       Date:  2016-11-11       Impact factor: 3.054

Review 9.  Cardiovascular risk in pediatric-onset rheumatological diseases.

Authors:  Julie Barsalou; Timothy J Bradley; Earl D Silverman
Journal:  Arthritis Res Ther       Date:  2013       Impact factor: 5.156

10.  Metabolomic Profiling Identifies Exogenous and Microbiota-Derived Metabolites as Markers of Methotrexate Efficacy in Juvenile Idiopathic Arthritis.

Authors:  Ryan Sol Funk; Mara L Becker
Journal:  Front Pharmacol       Date:  2021-12-09       Impact factor: 5.810
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.